Functional mu opioid receptor polymorphism (OPRM1 A118G) associated with heroin use outcomes in Caucasian males: A pilot study
dc.contributor.author | Woodcock, Eric A. | en_US |
dc.contributor.author | Lundahl, Leslie H. | en_US |
dc.contributor.author | Burmeister, Margit | en_US |
dc.contributor.author | Greenwald, Mark K. | en_US |
dc.date.accessioned | 2015-06-01T18:51:47Z | |
dc.date.available | 2016-07-05T17:27:58Z | en |
dc.date.issued | 2015-06 | en_US |
dc.identifier.citation | Woodcock, Eric A.; Lundahl, Leslie H.; Burmeister, Margit; Greenwald, Mark K. (2015). "Functional mu opioid receptor polymorphism (OPRM1 A118G) associated with heroin use outcomes in Caucasian males: A pilot study." The American Journal on Addictions 24(4): 329-335. | en_US |
dc.identifier.issn | 1055-0496 | en_US |
dc.identifier.issn | 1521-0391 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/111777 | |
dc.publisher | Sage Publications | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.title | Functional mu opioid receptor polymorphism (OPRM1 A118G) associated with heroin use outcomes in Caucasian males: A pilot study | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/111777/1/ajad12187.pdf | |
dc.identifier.doi | 10.1111/ajad.12187 | en_US |
dc.identifier.source | The American Journal on Addictions | en_US |
dc.identifier.citedreference | Rickham PP. Human experimentation. Code of ethics of the World Medical Association Declaration of Helsinki. Br Med J. 1964; 2: 177. | en_US |
dc.identifier.citedreference | Manini AF, Jacobs MM, Vlahov D, et al. Opioid receptor polymorphism A 118 G associated with clinical severity in a drug overdose population. J Med Toxicol. 2013; 2: 148 – 154. DOI: 10.1007/s13181‐012‐0286‐3. | en_US |
dc.identifier.citedreference | Wang YJ, Huang P, Ung A, et al. Reduced expression of the mu opioid receptor in some, but not all, brain regions in mice with OPRM1 A 112 G. Neuroscience. 2012b; 205: 178 – 184. DOI: 10.1016/j.neuroscience.2011.12.033 | en_US |
dc.identifier.citedreference | Greenwald MK, Hursh SR. Behavioral economic analysis of opioid consumption in heroin‐dependent individuals: Effects of unit price and pre‐session drug supply. Drug Alcohol Depend. 2006; 85: 35 – 48. DOI: 10.1016/j.drugalcdep.2006.03.007 | en_US |
dc.identifier.citedreference | Greenwald MK, Steinmiller CL. Behavioral economic analysis of opioid consumption in heroin‐dependent individuals: Effects of alternative reinforcer magnitude and post‐session drug supply. Drug Alcohol Depend. 2009; 104: 84 – 93. DOI: 10.1016/j.drugalcdep.2009.04.006 | en_US |
dc.identifier.citedreference | Greenwald MK. Effects of experimental unemployment, employment and punishment analogs on opioid seeking and consumption in heroin‐dependent volunteers. Drug Alcohol Depend. 2010; 111: 64 – 73. DOI: 10.1016/j.drugalcdep.2010.03.020 | en_US |
dc.identifier.citedreference | Greenwald MK, Lundahl LH, Steinmiller CL. Yohimbine increases opioid‐seeking behavior in heroin‐dependent, buprenorphine‐maintained individuals. Psychopharmacology. 2013; 225: 811 – 824. DOI: 10.1007/s00213‐012‐2868‐9. | en_US |
dc.identifier.citedreference | Hodgkinson CA, Yuan Q, Xu K, et al. Addictions biology: Haplotype‐based analysis for 130 candidate genes on a single array. Alcohol Alcohol. 2008; 43: 505 – 515. DOI: 10.1093/alcalc/agn032 | en_US |
dc.identifier.citedreference | West S.G., Finch J.F., Curran P.J., Structural equation models with nonnormal variables: Problems and remedies R.H. Hoyle, Structural equation modeling: Concepts, issues, and applications 1995 Newberry Park, CA: Sage Publications; 56 – 75. | en_US |
dc.identifier.citedreference | Barrio G, De La Fuente L, Lew C, et al. Differences in severity of heroin dependence by route of administration: The importance of length of heroin use. Drug Alcohol Depend. 2001; 63: 169 – 177. DOI: 10.1016/S0376‐8716(00)00204‐0. | en_US |
dc.identifier.citedreference | Gossop M, Griffiths P, Powis B, et al. Severity of dependence and route of administration of heroin, cocaine, and amphetamines. Br J Addict. 1992; 87: 1527 – 1536. | en_US |
dc.identifier.citedreference | Smolka M, Schmidt LG. The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome. Addiction. 1999; 94: 1191 – 1198. DOI: 10.1046/j.1360‐0443 | en_US |
dc.identifier.citedreference | Smyth BP, Barry J, Keenan E, et al. Lapse and relapse following treatment of opiate dependence. Ir Med J. 2010; 103: 176 – 179. | en_US |
dc.identifier.citedreference | Ray R, Jepson C, Patterson F, et al. Association of OPRM1 A 118 G variant with the relative reinforcing value of nicotine. Psychopharmacology (Berl). 2006; 188: 355 – 363. DOI: 10.1007/s00213‐006‐0504‐2. | en_US |
dc.identifier.citedreference | Munafò MR, Elliot KM, Murphy MF, et al. Association of the mu‐opioid receptor gene with smoking cessation. Pharmacogenomics J. 2007; 7: 353 – 361. DOI: 10.1038/sj.tpj.6500432 | en_US |
dc.identifier.citedreference | Kim SG. Gender differences in the genetic risk for alcohol dependence ‐ The results of a pharmacogenetic study in Korean alcoholics. Japanese Journal of Alcohol Studies & Drug Dependence 2009; 44: 680 – 685. | en_US |
dc.identifier.citedreference | Fillingim RB, Kaplan L, Staud R, et al. The A 118 G single nucleotide polymorphism of the μ‐opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain. 2005; 6: 159 – 167. DOI: 10.1016/j.jpain.2004.11.008 | en_US |
dc.identifier.citedreference | Raynor K, Kong H, Chen Y, et al. Pharmacological characterization of the cloned kappa‐, delta‐, and mu‐opioid receptors. Mol Pharmacol. 1994; 45: 330 – 334. | en_US |
dc.identifier.citedreference | Lalley PM. Opioidergic and dopaminergic modulation of respiration. Respir Physiol Neurobiol. 2008; 164: 160 – 167. DOI: 10.1016/j.resp.2008.02.004 | en_US |
dc.identifier.citedreference | Zhang Z, Zhuang J, Zhang C, et al. Activation of opioid μ‐receptors in the commissural subdivision of the nucleus tractus solitarius abolishes the ventilatory response to hypoxia in anesthetized rats. Anesthesiology 2011; 115: 353 – 363. DOI: 10.1097/ALN.0b013e318224cc1f | en_US |
dc.identifier.citedreference | Bergen AW, Kokoszka J, Peterson R, et al. Mu opioid receptor gene variants: Lack of association with alcohol dependence. Mol Psychiatry. 1997; 2: 490 – 494. DOI: 10.1038/sj.mp.4000331 | en_US |
dc.identifier.citedreference | Bond C, LaForge KS, Tian M, et al. Single‐nucleotide polymorphism in the human mu opioid receptor gene alters β‐endorphin binding and activity: Possible implications for opiate addiction. Proc Natl Acad Sci USA. 1998; 95: 9608 – 9613. | en_US |
dc.identifier.citedreference | Zhang Y, Wang D, Johnson AD, et al. Allelic expression imbalance of human mu opioid receptor ( OPRM1 ) caused by variant A 118 G. J Biol Chem. 2005; 280: 32618 – 32624. DOI: 10.1074/jbc.M504942200 | en_US |
dc.identifier.citedreference | Oertel BG, Doehring A, Roskam B, et al. Genetic‐epigenetic interaction modulates μ‐opioid receptor regulation. Hum Mol Genet. 2012; 21: 4751 – 4760. DOI: 10.1093/hmg/dds314 | en_US |
dc.identifier.citedreference | Wang YJ, Huang P, Blendy JA, et al. Brain region‐ and sex‐specific alterations in DAMGO‐stimulated [(35) S]GTPgammaS binding in mice with OPRM1 A 112 G. Addict Biol. 2012a; 19: 354 – 361. DOI: 10.1111/j.1369‐1600.2012.00484.x | en_US |
dc.identifier.citedreference | Yaksh TL, Yeung JC, Rudy TA. Systematic examination in the rat of brain sites sensitive to the direct application of morphine: Observation of differential effects within the periaqueductal gray. Brain Res. 1976; 114: 83 – 103. | en_US |
dc.identifier.citedreference | Ingvar M. Pain and functional imaging. Philos Trans R Soc Lond B Biol Sci. 1999; 354: 1347 – 1358. DOI: 10.1098/rstb.1999.0483 | en_US |
dc.identifier.citedreference | Peyron R, Laurent B, Garcia‐Larrea L. Functional imaging of brain responses to pain. A review and meta‐analysis. Clin Neurophysiol. 2000; 30: 263 – 288. DOI: 10.1016/S0987‐7053(00)00227‐6. | en_US |
dc.identifier.citedreference | Mague SD, Isiegas C, Huang P, et al. Mouse model of OPRM1 (A 118 G) polymorphism has sex‐specific effects on drug‐mediated behavior. Proc Natl Acad Sci USA. 2009; 106: 10847 – 10852. DOI: 10.1073/pnas.0901800106 | en_US |
dc.identifier.citedreference | Chou WY, Wang CH, Liu PH. Human opioid receptor A 118 G polymorphism affects intravenous patient‐controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology. 2006a; 105: 334 – 337. | en_US |
dc.identifier.citedreference | Chou WY, Yang LC, Lu HF, et al. Association of mu‐opioid receptor gene polymorphism (A 118 G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand. 2006b; 50: 787 – 792. DOI: 10.1111/j.1399‐6576.2006.01058.x | en_US |
dc.identifier.citedreference | Sia AT, Lim Y, Lim EC, et al. A 118 G single nucleotide polymorphism of human mu‐opioid receptor gene influences pain perception and patient‐controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology. 2008; 109: 520 – 526. DOI: 10.1097/ALN.0b013e318182af21 | en_US |
dc.identifier.citedreference | Tan EC, Lim EC, Teo YY, et al. Ethnicity and OPRM1 variant independently predict pain perception and patient‐controlled analgesia usage for post‐operative pain. Mol Pain. 2009; 5: 1 – 8. DOI: 10.1186/1744‐8069‐5‐32. | en_US |
dc.identifier.citedreference | Huang P, Chen C, Mague SD, et al. A common single nucleotide polymorphism A 118 G of the mu opioid receptor alters its N‐glycosylation and protein stability. Biochem J. 2012; 441: 379 – 386. DOI: 10.1042/BJ20111050 | en_US |
dc.identifier.citedreference | Beyer A, Koch T, Schroder H, et al. Effect of the A 118 G polymorphism on binding affinity, potency, and agonist‐mediated endocytosis, desensitization, and resensitization of the human mu ‐opioid receptor. J Neurochem. 2004; 89: 553 – 560. DOI: 10.1111/j.1471‐4159.2004.02340.x | en_US |
dc.identifier.citedreference | Kroslak T, LaForge KS, Gianotti RJ, et al. The single nucleotide polymorphism A 118 G alters functional properties of the human mu opioid receptor. J Neurochem. 2007; 103: 77 – 87. DOI: 10.1111/j.1471‐4159.2007.04738.x | en_US |
dc.identifier.citedreference | Ray R, Ruparel K, Newberg A, et al. Human mu opioid receptor (OPRM1 A 118 G) polymorphism is associated with brain mu‐opioid receptor binding potential in smokers. Proc Natl Acad Sci USA. 2011; 108: 9268 – 9273. DOI: 10.1073/pnas.1018699108 | en_US |
dc.identifier.citedreference | Weerts EM, McCaul ME, Kuwabara H, et al. Influence of OPRM1 Asn40Asp variant (A 118 G) on [11C]carfentanil binding potential: Preliminary findings in human subjects. Int J Neuropsychopharmacol. 2013; 16: 47 – 53. DOI: 10.1017/S146114571200017X | en_US |
dc.identifier.citedreference | Coller JK, Beardsley J, Bignold J, et al. Lack of association between the A 118 G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta‐analysis. Pharmacogenomics Pers Med. 2009; 2: 9 – 19. | en_US |
dc.identifier.citedreference | Arias A, Feinn R, Kranzler HR. Association of an Asn40Asp (A 118 G) polymorphism in the μ‐opioid receptor gene with substance dependence: A meta analysis. Drug Alcohol Depend. 2006; 83: 262 – 268. DOI: 10.1016/j.drugalcdep.2005.11.024 | en_US |
dc.identifier.citedreference | Haerian BS, Haerian MS. OPRM1 rs1799971 polymorphism and opioid dependence: Evidence from a meta‐analysis. Pharmacogenomics. 2013; 7: 813 – 824. DOI: 10.2217/pgs.13.57 | en_US |
dc.identifier.citedreference | Kreek MJ, Nielsen DA, Butelman ER, et al. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nature Neuroscience. 2005; 8: 1450 – 1457. DOI: 10.1038/nn1583 | en_US |
dc.identifier.citedreference | Khokhar JY, Ferguson CS, Zhu AZ, et al. Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment. Annu Rev Pharmacol Toxicol. 2010; 50: 39 – 61. DOI: 10.1146/annurev.pharmtox.010909.105826 | en_US |
dc.identifier.citedreference | Nikolov MA, Beltcheva O, Galabova A, et al. No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case‐control sample. Drug Alcohol Depend. 2011; 117: 62 – 65. DOI: 10.1016/j.drugalcdep.2010.12.026 | en_US |
dc.identifier.citedreference | Shi J, Hui L, Xu Y, et al. Sequence variations in the mu‐opioid receptor gene (OPRM1) associated with human addiction to heroin. Human Mutat. 2002; 19: 459 – 460. DOI: 10.1002/humu.9026 | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.